APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 24 filers reported holding APTEVO THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,951 | -78.2% | 221,064 | -3.4% | 0.00% | – |
| Q2 2023 | $334,083 | -28.4% | 228,824 | -0.2% | 0.00% | – |
| Q1 2023 | $466,748 | -15.8% | 229,360 | -4.0% | 0.00% | – |
| Q4 2022 | $554,434 | -23.6% | 238,980 | +0.1% | 0.00% | – |
| Q3 2022 | $726,000 | -15.1% | 238,844 | 0.0% | 0.00% | – |
| Q2 2022 | $855,000 | -39.5% | 238,844 | -0.8% | 0.00% | – |
| Q1 2022 | $1,414,000 | -19.9% | 240,819 | +7.3% | 0.00% | – |
| Q4 2021 | $1,766,000 | -15.4% | 224,482 | +65.9% | 0.00% | – |
| Q3 2021 | $2,088,000 | -30.9% | 135,272 | +0.4% | 0.00% | – |
| Q2 2021 | $3,022,000 | -24.4% | 134,760 | +2.9% | 0.00% | – |
| Q1 2021 | $3,997,000 | -27.6% | 130,930 | -13.1% | 0.00% | – |
| Q4 2020 | $5,523,000 | +877.5% | 150,702 | +102.4% | 0.00% | – |
| Q3 2020 | $565,000 | +14.4% | 74,462 | +25.9% | 0.00% | – |
| Q2 2020 | $494,000 | +121.5% | 59,161 | -1.9% | 0.00% | – |
| Q1 2020 | $223,000 | – | 60,309 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,334,169 | $440,276 | 0.32% |
| ARMISTICE CAPITAL, LLC | 1,235,000 | $407,550 | 0.01% |
| Divergent Wealth Advisors | 10,000 | $3,300 | 0.00% |
| FIFTH THIRD BANCORP | 291 | $96 | 0.00% |
| FRANKLIN RESOURCES INC | 10,997 | $3,629 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 6 | $2 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 142 | $47 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,562 | $515 | 0.00% |
| NORTHERN TRUST CORP | 14,121 | $4,660 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |